mRNA IP and Competitive Landscape: 2021 in Review – Part II, Sanofi, Startups …

27th December 2021

eTheRNA is still listed as filing eight oppositions (against CureVac’s patents) and no IPRs. Abogen Biosciences, an mRNA startup based in Suzhou, …